382 results on '"Giannitrapani, Lydia"'
Search Results
2. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis
3. COVID in 2022. Clinical risk management of sars-cov-2 positive patients admitted to an internal medicine ward
4. The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy
5. TOP-193 Consumption of a mediterranean diet with high-polyphenol content extra-virgin olive oil (EVOO) in patients with MASLD: effects on clinical parameters and gene expression on peripheral blood mononuclear cells (PBMCs)
6. Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort
7. Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI
8. Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?
9. Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome
10. HepaDisk – A new quality of life questionnaire for HCV patients
11. Real Life Experience on the Use of Remdesivir in Patients Admitted to Covid-19 in Two Referral Italian Hospital: a Propensity Score Matched Analysis
12. Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study
13. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
14. Genetic biomarkers of sorafenib response in patients with hepatocellular carcinoma
15. Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study
16. Genetic biomarkers for sorafenib response in patients with hepatocellular carcinoma
17. Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma.
18. Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome
19. COVID in 2022. Clinical risk management of sars-cov-2 positive patients admitted to an internal medicine ward
20. Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult
21. Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
22. EVOO’s Effects on Incretin Production: Is There a Rationale for a Combination in T2DM Therapy?
23. Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases
24. The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach
25. Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population
26. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
27. Long-term follow-up of hepatitis C virus-positive patients with persistently normal serum transaminases
28. Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection
29. SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease
30. Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results
31. Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease?
32. The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?
33. The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma
34. The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine
35. Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance
36. Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort
37. Response to the Letter to the editor regarding “Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma” by Jiong Lin
38. SAT-288 - Genetic biomarkers for sorafenib response in patients with hepatocellular carcinoma
39. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response
40. Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies
41. Hepatocellular Carcinoma: A Difficult Cancer to Treat
42. Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis
43. Leucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-Interferons
44. Circulating E-Selectin Levels in Chronic Hepatitis C Patients with Normal or Elevated Transaminase Before and After Alpha-Interferon Treatment
45. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
46. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response
47. Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study
48. Second-generation DAAs for HCV: real-life efficacy in the resist-HCV cohort
49. Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma
50. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.